Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

146.71
Delayed Data
As of Feb 24
 -0.73 / -0.50%
Today’s Change
97.52
Today|||52-Week Range
169.89
+2.29%
Year-to-Date

Today’s Trading

Previous close147.44
Today’s open145.96
Day’s range145.57 - 147.19
Volume414,114
Average volume (3 months)603,296
Market cap$6.6B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)--
Earnings growth (next 5 years)+16.65%
Revenue growth (last year)+9.08%
P/E ratio9.8
Price/Sales4.20
Price/Book3.40

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.20-0.46%
MNKMallinckrodt Plc-1.09-2.00%
VRXValeant Pharmaceutic...-0.40-2.41%
IONSIonis Pharmaceutical...+0.24+0.54%
Data as of 4:02pm ET, 02/24/2017

Financials

Last reporting dateFebruary 22, 2017
EPS forecast (this quarter)$3.56
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts


Search for Jobs